← All trials
NCT04898738
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2021
- Primary completion
- Sep 30, 2022
- Completion date
- Sep 30, 2022
- First posted
- May 24, 2021
- Last posted
- May 24, 2021
- Enrollment
- 2000
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Harvard UniversityLead sponsor
- University of LondonCollaborator
- University of QueenslandCollaborator
- Harvard UniversityReponsible party - principal investigator
- Harvard UniversityOverall official - principal investigator
- Yale UniversityCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
- Broad InstituteCollaborator
- Government of Dominican RepublicCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.